Fosaprepitant
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Fosaprepitant, sold under the brand names Emend (US) and Ivemend (EU) among others, is an antiemetic medication,[1] administered intravenously. It is a prodrug of aprepitant.
Fosaprepitant was developed by Merck & Co. and was approved for medical use in the United States,[2] and in the European Union in January 2008.[3]
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox". Template:Neurokinin receptor modulators Template:Portal bar
Template:Gastrointestinal-drug-stub
Template:Nervous-system-drug-stub